Mario von Depka Prondzinski
Department of Haematology and Oncology
Hannover Medical School
Germany
Name/email consistency: high
- Immune tolerance therapy in patients with acquired hemophilia. von Depka, M. Hematology (2004)
- The deletion polymorphism in the angiotensin-converting enzyme gene is a moderate risk factor for venous thromboembolism. von Depka, M., Czwalinna, A., Wermes, C., Eisert, R., Scharrer, I., Ganser, A., Ehrenforth, S. Thromb. Haemost. (2003)
- NovoSeven: mode of action and use in acquired haemophilia. Von Depka, M. Intensive. Care. Med (2002)
- Prevalence of a 23bp insertion in exon 3 of the endothelial cell protein C receptor gene in venous thrombophilia. von Depka, M., Czwalinna, A., Eisert, R., Wermes, C., Scharrer, I., Ganser, A., Ehrenforth, S. Thromb. Haemost. (2001)
- Anticoagulant prophylaxis and therapy in patients with cancer. von Depka Prondzinski, M., Karthaus, M., Ganser, A., Barthels, M. Antibiot. Chemother (2000)